UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CXE
4351
DELISTED
MFS High Income Municipal Trust
CXE
| $2.9M | ﹤0.01% |
789,124
-25,120
| -3% | -$96.2K |
|
4352
CALL
Teck Resources
TECK
$32.6B
| $2.9M | ﹤0.01% |
71,618
+20,100
| +39% | +$939K |
|
4353
Calumet Specialty Products
CLMT
$3.44B
| $2.9M | ﹤0.01% |
131,705
-55,519
| -30% | -$1.17M |
|
|
CCD
4354
Calamos Dynamic Convertible & Income Fund
CCD
$742M
| $2.9M | ﹤0.01% |
119,277
+10,449
| +10% | +$256K |
|
|
EMD
4355
Western Asset Emerging Markets Debt Fund
EMD
$616M
| $2.89M | ﹤0.01% |
300,729
-158,790
| -35% | -$1.58M |
|
4356
Danaos Corp
DAC
$2.56B
| $2.89M | ﹤0.01% |
36,127
+35,826
| +11,902% | +$2.95M |
|
4357
Hyliion Holdings
HYLN
$690M
| $2.89M | ﹤0.01% |
1,107,794
+903,301
| +442% | +$2.51M |
|
4358
ProShares Ultra QQQ
QLD
$14.1B
| $2.89M | ﹤0.01% |
53,400
+43,510
| +440% | +$2.33M |
|
4359
Weibo
WB
$1.95B
| $2.89M | ﹤0.01% |
302,543
+209,267
| +224% | +$2M |
|
4360
Innoviz Technologies
INVZ
$112M
| $2.88M | ﹤0.01% |
1,715,695
+1,682,732
| +5,105% | +$1.39M |
|
|
PMO
4361
Franklin Municipal Opportunities Trust
PMO
$285M
| $2.87M | ﹤0.01% |
283,668
+26,506
| +10% | +$279K |
|
4362
iShares MSCI Turkey ETF
TUR
$213M
| $2.87M | ﹤0.01% |
80,101
-18,464
| -19% | -$648K |
|
4363
Compass Minerals
CMP
$1.15B
| $2.87M | ﹤0.01% |
255,260
+182,157
| +249% | +$2.38M |
|
|
PLYM
4364
DELISTED
Plymouth Industrial REIT
PLYM
| $2.87M | ﹤0.01% |
161,330
+17,273
| +12% | +$341K |
|
|
IRS
4365
IRSA Inversiones y Representaciones
IRS
$1.26B
| $2.87M | ﹤0.01% |
192,333
+133,939
| +229% | +$1.9M |
|
4366
Cullinan Oncology
CGEM
$1.14B
| $2.87M | ﹤0.01% |
235,713
+50,160
| +27% | +$721K |
|
4367
Invesco DB Agriculture Fund
DBA
$1.23B
| $2.87M | ﹤0.01% |
107,924
-1,858
| -2% | -$48.5K |
|
4368
Zevra Therapeutics
ZVRA
$686M
| $2.87M | ﹤0.01% |
343,818
+323,884
| +1,625% | +$2.76M |
|
|
JMIA
4369
Jumia Technologies
JMIA
$767M
| $2.87M | ﹤0.01% |
750,390
+697,055
| +1,307% | +$3.13M |
|
4370
CALL
State Street
STT
$50.7B
| $2.87M | ﹤0.01% |
29,200
+10,000
| +52% | +$947K |
|
4371
Nu Skin
NUS
$267M
| $2.86M | ﹤0.01% |
415,807
+326,753
| +367% | +$2.25M |
|
4372
CALL
Kohl's
KSS
$2.19B
| $2.86M | ﹤0.01% |
203,718
-1,657,535
| -89% | -$28.6M |
|
|
FINV
4373
CALL
FinVolution Group
FINV
$1.15B
| $2.86M | ﹤0.01% |
421,120
-2,539,208
| -86% | -$16.3M |
|
|
UNIT
4374
Uniti Group
UNIT
$2.32B
| $2.86M | ﹤0.01% |
519,660
+222,387
| +75% | +$1.26M |
|
|
PPL
4375
CALL
PPL Corp
PPL
$26.7B
| $2.86M | ﹤0.01% |
88,000
+40,000
| +83% | +$1.32M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.